Insider Shareholders with Direct Ownership of Immunome Inc. (IMNM)
This section provides a comprehensive overview of the insiders with direct ownership of Immunome Inc. (IMNM). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Immunome Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Michael Rapp
Director |
910,192 | 0 | 1,071,172 $18.4 Million | 3 |
Oct 02, 2023
Added 19.16%
|
|
I Wistar Morris Iii
> 10% Shareholder |
882,475 | 0 | 882,475 $15.1 Million | 1 |
Oct 06, 2020
Added 50.0%
|
|
Clay B Siegall
President and CEO |
710,093 | 200,000 | 660,525 $11.3 Million | 10 |
Dec 19, 2025
Reduced 23.24%
|
| 22,250 | 0 | 406,147 $6.96 Million | 2 |
Jan 15, 2023
Added 2.11%
|
|
|
John L Lamattina
Director |
66,953 | 0 | 66,953 $1.15 Million | 3 |
Jan 15, 2023
Added 18.43%
|
|
Franklyn G Prendergast
Director |
60,840 | 0 | 60,840 $1.04 Million | 1 |
Oct 02, 2023
Added 50.0%
|
|
Michael Widlitz
Director |
51,315 | 0 | 51,315 $879,539 | 1 |
Oct 06, 2020
Added 50.0%
|
|
Max Rosett
Chief Financial Officer |
42,000 | 14,380 | 47,476 $813,738 | 2 |
Sep 19, 2024
Reduced 23.25%
|
|
Philip Tsai
Chief Technical Officer |
43,300 | 0 | 43,300 $742,162 | 3 |
Dec 19, 2025
Added 18.76%
|
|
Bruce Turner
Chief Strategy Officer |
42,300 | 0 | 42,300 $725,022 | 1 |
Oct 02, 2023
Added 50.0%
|
|
Michael Lefenfeld
Director |
40,747 | 0 | 40,747 $698,403 | 5 |
Jan 15, 2023
Added 25.4%
|
|
Jack Higgins
Chief Scientific Officer |
46,724 | 8,995 | 40,729 $698,095 | 6 |
Sep 10, 2025
Added 35.07%
|
| 28,800 | 0 | 36,415 $624,153 | 5 |
Jun 03, 2025
Added 12.07%
|
|
|
Robert Lechleider
Chief Medical Officer |
15,805 | 0 | 15,805 $270,897 | 1 |
Nov 21, 2024
Added 50.0%
|
|
Purnanand D Sarma
President and CEO |
10,500 | 0 | 10,500 $179,970 | 1 |
May 25, 2021
Added 50.0%
|
|
Richard A Baron
Director |
2,343 | 0 | 2,343 $40,159 | 1 |
Aug 18, 2021
Added 50.0%
|